Abionic SA-医療機器分野:企業M&A・提携分析

◆英語タイトル:Abionic SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011359
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company offers products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone & iPad, and accessories. Its abioSCOPE in vitro tests are designed to deliver specific, semi-quantitative and personalized information about patients’ allergen sensitization at the point ofcare. Abionic’s abioGUIDE application allows the user to see the results from the abioSCOPE directly on mobile platform. The company’s IVD capsule test provides accurate information about your patients’ respiratory allergies from a drop of blood. Its AbioGUIDE provides access to a complete database, showing cross-reactions with other allergens, as well as illustrations. Abionic is headquartered in Lausanne, Switzerland.

Abionic SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abionic SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Abionic SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Abionic SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Abionic SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Abionic SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Abionic SA, Medical Equipment, Deal Details 10
Venture Financing 10
Abionic Raises USD4 Million in Series B Venture Financing 10
Abionic Raises US$2 Million In First Financing Round 11
Partnerships 12
Lascco Enters into Partnership with Abionic 12
Abionic SA – Key Competitors 13
Abionic SA – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Corporate Communications 15
Dec 06, 2017: Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Abionic SA, Medical Equipment, Key Facts 2
Abionic SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Abionic SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Abionic SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Abionic SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Abionic SA, Deals By Market, 2011 to YTD 2017 8
Abionic SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Abionic Raises USD4 Million in Series B Venture Financing 10
Abionic Raises US$2 Million In First Financing Round 11
Lascco Enters into Partnership with Abionic 12
Abionic SA, Key Competitors 13

★海外企業調査レポート[Abionic SA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tupras (Turkish Petroleum Refineries Co):企業の戦略・SWOT・財務分析
    Tupras (Turkish Petroleum Refineries Co) - Strategy, SWOT and Corporate Finance Report Summary Tupras (Turkish Petroleum Refineries Co) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Orlando Utilities Commission:電力:M&Aディール及び事業提携情報
    Summary Orlando Utilities Commission (OUC) is a municipally-owned public utility that provides water and electric services. The commission generates, transmits, and distributes electricity and water to residential and commercial customers. It also constructs, operates and maintains electric and wate …
  • Hsh Nordbank Private Banking:企業の戦略・SWOT・財務分析
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of co …
  • Kronos Incorporated:企業の戦略・SWOT・財務情報
    Kronos Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kronos Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fingrid Oyj:発電所・企業SWOT分析
    Fingrid Oyj - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Glenmark Pharmaceuticals Ltd (GLENMARK):企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • JetBlue Airways Corp:企業の戦略・SWOT・財務情報
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gevo, Inc.:企業のM&A・事業提携・投資動向
    Gevo, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gevo, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Alnylam Pharmaceuticals Inc (ALNY):医療機器:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Banco do Nordeste SA:企業の戦略・SWOT・財務分析
    Banco do Nordeste SA - Strategy, SWOT and Corporate Finance Report Summary Banco do Nordeste SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Avacta Group Plc (AVCT):企業の財務・戦略的SWOT分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Stryker Corporation (SYK)-医療機器分野:企業M&A・提携分析
    Summary Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communicatio …
  • Centamin Plc:企業の戦略・SWOT・財務情報
    Centamin Plc - Strategy, SWOT and Corporate Finance Report Summary Centamin Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Beijing Enterprises Holdings Limited:戦略・SWOT・企業財務分析
    Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Cosumar SA:戦略・SWOT・企業財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MilliporeSigma:企業の戦略的SWOT分析
    MilliporeSigma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆